ROTHBLATT MARTINE A
SEC CIK 1106578 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $844.54M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 665
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-12 | 2025-12-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DTI | 2025-12-10 | 2025-12-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | $0.00 | -5,000 | 11.0K | -31% | $0 |
| DMT | 2025-12-10 | 2025-12-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-10 | 2025-12-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $479.17 | -8,000 | 130 | -98% | -$3.83M |
| DMT | 2025-12-08 | 2025-12-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-08 | 2025-12-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $483.76 | -8,000 | 3,122 | -72% | -$3.87M |
| DMT | 2025-12-05 | 2025-12-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-05 | 2025-12-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $477.64 | -8,000 | 2,725 | -75% | -$3.82M |
| DMT | 2025-12-02 | 2025-12-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $481.61 | -8,000 | 1,861 | -81% | -$3.85M |
| DMT | 2025-12-02 | 2025-12-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-01 | 2025-11-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $486.35 | -8,000 | 630 | -93% | -$3.89M |
| DMT | 2025-12-01 | 2025-11-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-25 | 2025-11-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $473.05 | -8,000 | 430 | -95% | -$3.78M |
| DMT | 2025-11-25 | 2025-11-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-21 | 2025-11-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $476.51 | -8,000 | 130 | -98% | -$3.81M |
| DMT | 2025-11-21 | 2025-11-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-20 | 2025-11-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $473.67 | -8,000 | 130 | -98% | -$3.79M |
| DMT | 2025-11-20 | 2025-11-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-18 | 2025-11-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $465.25 | -8,000 | 130 | -98% | -$3.72M |
| DMT | 2025-11-18 | 2025-11-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-13 | 2025-11-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $594.48 | -8,000 | 3,630 | -69% | -$4.76M |
| DMT | 2025-11-13 | 2025-11-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-12 | 2025-11-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $450.11 | -8,000 | 630 | -93% | -$3.60M |
| DMT | 2025-11-12 | 2025-11-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-07 | 2025-11-06+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $448.41 | -8,000 | 1,610 | -83% | -$3.59M |
| DMT | 2025-11-07 | 2025-11-06+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-06 | 2025-11-04+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-11-06 | 2025-11-04+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $436.05 | -8,000 | 1,130 | -88% | -$3.49M |
| DMT | 2025-11-04 | 2025-10-31+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $444.33 | -8,000 | 2,593 | -76% | -$3.55M |
| DMT | 2025-11-04 | 2025-10-31+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-31 | 2025-10-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-31 | 2025-10-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $442.37 | -8,000 | 2,089 | -79% | -$3.54M |
| DMT | 2025-10-30 | 2025-10-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $415.47 | -8,000 | 130 | -98% | -$3.32M |
| DMT | 2025-10-30 | 2025-10-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-27 | 2025-10-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $423.13 | -8,000 | 1,193 | -87% | -$3.39M |
| DMT | 2025-10-27 | 2025-10-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-22 | 2025-10-21+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $424.95 | -8,000 | 3,496 | -70% | -$3.40M |
| DMT | 2025-10-22 | 2025-10-21+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-20 | 2025-10-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-20 | 2025-10-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $427.63 | -8,000 | 2,531 | -76% | -$3.42M |
| DMT | 2025-10-16 | 2025-10-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $433.30 | -8,000 | 3,130 | -72% | -$3.47M |
| DMT | 2025-10-16 | 2025-10-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-15 | 2025-10-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $438.95 | -8,000 | 3,608 | -69% | -$3.51M |
| DMT | 2025-10-15 | 2025-10-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-10 | 2025-10-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $446.81 | -8,000 | 3,130 | -72% | -$3.57M |
| DMT | 2025-10-10 | 2025-10-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-08 | 2025-10-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-08 | 2025-10-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $451.35 | -8,000 | 2,030 | -80% | -$3.61M |
| DMT | 2025-10-06 | 2025-10-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-06 | 2025-10-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $447.95 | -8,000 | 130 | -98% | -$3.58M |
| DMT | 2025-10-02 | 2025-10-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $430.17 | -8,000 | 3,050 | -72% | -$3.44M |
| DMT | 2025-10-02 | 2025-10-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-01 | 2025-09-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-10-01 | 2025-09-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $424.24 | -8,000 | 130 | -98% | -$3.39M |
| DM | 2025-09-29 | 2025-09-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $429.58 | -8,000 | 130 | -98% | -$3.44M |
| DM | 2025-09-29 | 2025-09-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-25 | 2025-09-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $426.14 | -8,000 | 2,130 | -79% | -$3.41M |
| DMT | 2025-09-25 | 2025-09-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-22 | 2025-09-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $414.19 | -8,000 | 2,130 | -79% | -$3.31M |
| DMT | 2025-09-22 | 2025-09-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-18 | 2025-09-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $402.30 | -8,000 | 2,130 | -79% | -$3.22M |
| DMT | 2025-09-18 | 2025-09-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-17 | 2025-09-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $400.26 | -4,000 | 130 | -97% | -$1.60M |
| DT | 2025-09-17 | 2025-09-16 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +4,000 | 4,130 | +3,077% | +$481.0K |
| DM | 2025-09-16 | 2025-09-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $400.93 | -8,000 | 3,130 | -72% | -$3.21M |
| DM | 2025-09-16 | 2025-09-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-11 | 2025-09-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $397.98 | -8,000 | 130 | -98% | -$3.18M |
| DMT | 2025-09-11 | 2025-09-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-10 | 2025-09-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $398.55 | -8,000 | 1,965 | -80% | -$3.19M |
| DT | 2025-09-10 | 2025-09-09 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 8,130 | +6,154% | +$962.1K |
| MI | 2025-03-11 | 2025-03-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | $0.00 | 0 | 16.0K | New | $0 |
| DM | 2024-08-28 | 2024-08-26 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $348.41 | -269 | 371 | -42% | -$93.7K |
| D | 2024-08-28 | 2024-08-26 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +269 | 399 | +207% | +$34.8K |
| DM | 2024-08-26 | 2024-08-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $347.47 | -7,200 | 1,785 | -80% | -$2.50M |
| DM | 2024-08-26 | 2024-08-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-22 | 2024-08-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $348.08 | -7,200 | 2,784 | -72% | -$2.51M |
| DM | 2024-08-22 | 2024-08-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-21 | 2024-08-19 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $344.18 | -3,600 | 178 | -95% | -$1.24M |
| D | 2024-08-21 | 2024-08-19 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +3,600 | 3,730 | +2,769% | +$466.2K |
| DM | 2024-08-19 | 2024-08-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $322.00 | -7,200 | 130 | -98% | -$2.32M |
| DM | 2024-08-19 | 2024-08-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-15 | 2024-08-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $326.17 | -7,200 | 3,137 | -70% | -$2.35M |
| DM | 2024-08-15 | 2024-08-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-13 | 2024-08-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $332.31 | -7,200 | 130 | -98% | -$2.39M |
| DM | 2024-08-13 | 2024-08-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-09 | 2024-08-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $326.20 | -7,200 | 733 | -91% | -$2.35M |
| DM | 2024-08-09 | 2024-08-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-07 | 2024-08-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $323.55 | -7,200 | 1,848 | -80% | -$2.33M |
| DM | 2024-08-07 | 2024-08-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-08-05 | 2024-08-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $324.32 | -7,200 | 3,347 | -68% | -$2.34M |
| DM | 2024-08-05 | 2024-08-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| D | 2024-08-02 | 2024-07-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +3,600 | 3,730 | +2,769% | +$466.2K |
| DM | 2024-08-02 | 2024-07-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $318.39 | -3,600 | 1,771 | -67% | -$1.15M |
| DM | 2024-07-31 | 2024-07-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $336.56 | -7,200 | 3,501 | -67% | -$2.42M |
| DM | 2024-07-31 | 2024-07-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-29 | 2024-07-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $338.75 | -7,200 | 3,600 | -67% | -$2.44M |
| DM | 2024-07-29 | 2024-07-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-25 | 2024-07-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $334.69 | -7,200 | 1,733 | -81% | -$2.41M |
| DM | 2024-07-25 | 2024-07-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-23 | 2024-07-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
Purchase Sale Sale after option exercise All abbreviations